Search Results
Search results for "Design Pharmaceuticals"
Results found for "Design Pharmaceuticals"
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
They design assays differently. They interpret deviations differently. Kenakin  noted, it wasn’t designed.
- Fusion protein strategies for cryo-EM study of G protein-coupled receptors
Here, we address this shortcoming by exploring different fusion protein designs, which lead to structures
- GPCR Buzz of the Week | Sep 23 - 29, 2024
November 14th : The Application of GPCR Ligand Kinetics to Candidate Design. potential agonists of orphan receptor GPR78 targeting CNS disorders Predicting biological activity and design
- G protein coupling and activation of the metabotropic GABAB heterodimer
provides fresh insights into the mechanistic details of class C GPCRs activation expected to be useful for designing
- Structure of the human galanin receptor 2 bound to galanin and Gq reveals the basis of ligand...
understand the basis of the ligand preferences of the receptors and to assist structure-based drug design
- Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
findings fill a gap in the understanding of CB1 allosteric regulation and could guide the rational design
- Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
the identification of allosteric sites as well as ligand-based and structure-based drug discovery and design
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
reported intracellular CCR2 antagonists, several tetramethylrhodamine (TAMRA)-labeled CCR2 ligands were designed
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This talk gave a general idea of what goes into designing small molecule drugs, using state-of-the-art
- 📰 GPCR Weekly News, November 20 to 26, 2023
Insights into GPCR Function Structural and signaling mechanisms of TAAR1 enabled preferential agonist design Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones
- Accelerating GPCR Drug Discovery
Systems That Drive Progress: Â From assay tracking to data workflows, I design simple, scalable tools
- Functional modulation of PTH1R activation and signaling by RAMP2
GPCR that may provide a new venue for highly specific modulation of GPCR function and advanced drug design
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
role, she will focus on the application of artificial intelligence (AI), machine learning, and the design
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
who has just released an incredible article on our site and a GPCR Paper with his team: Targeted Drug Design November 14th : The Application of GPCR Ligand Kinetics to Candidate Design.
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
aGPCRs via post-translational modifications of the Go protein, and offers guidance for future drug design
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
, which clarifies the receptor subtype selectivity and provides a template for structure-based drug design
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Our updated course schedule is designed to fit seamlessly into your routine, offering an enriched learning  Boston, MA 📅 October 2 -3, 2024 Join top researchers to explore the latest in GPCR-targeted drug design
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
understandings of CB2 signaling, tools that preserve cellular context will be increasingly important for designing Three-dimensional quantitative structure–selectivity relationships analysis guided rational design of
- Choosing the Right GPCR Calcium Assay Readout for Measuring Receptor Activation
fluorescent or luminescent calcium measurements depending on instrumentation preferences and assay design PathHunter® Assays and Calcium Signaling Although PathHunter assays are primarily designed to measure
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
brain vs. peripheral contributions to metabolic therapy Guide how next-generation incretin drugs are designed
- Dr. GPCR and GeneTex Partner to Engage the Community on Anti-GPCR Antibody Challenges
Community feedback is central to how this partnership is designed to work.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor Design
- Pharmacological Properties and Function of PxOctβ3 Octopamine Receptor in Plutella xylostella (L.)
pharmacological properties and functions of PxOctβ3 in P. xylostella, thus, providing a theoretical basis for the design
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
that our results could have potential implications in structural biological advancements of GPCRs and design
- From GPCR Data Chaos to Decisive Action
Here’s what I bring: Biology-First Strategy I’ve designed GPCR assays, led collaborations across research
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma and Antiverse Enter Collaboration To Design Using Generative AI Zombie Fungi Hijack Hosts’ Brains GPCR Therapeutics, Inc. has received Orphan Drug Designation
- 📰 GPCR Weekly News, February 19 to 25, 2024
restoration of tension in epithelial cells GPCR Binders, Drugs, and more Advances in structure-based drug design copolymers and SMALPs as a platform for investigating GPCRs Reviews, GPCRs, and more Fragment-Based Design
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based drug design
- GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event
Whether you're decoding signaling pathways or designing the next generation of therapeutics, Revvity
- Beyond HEK293 — Terry Hébert on iPSC-Derived GPCR Models, Live April 16,
producing a fundamentally different pharmacological pattern — with different consequences for assay design















